These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 32061107)

  • 1. Calculated body muscle mass as a useful screening marker for low skeletal muscle mass and sarcopenia in chronic liver disease.
    Ichikawa T; Miyaaki H; Miuma S; Motoyoshi Y; Yamashima M; Yamamichi S; Koike M; Honda T; Yajima H; Uehara R; Miyazaki O; Hino N; Hirata R; Taura N; Nakao K
    Hepatol Res; 2020 Jun; 50(6):704-714. PubMed ID: 32061107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indices calculated by serum creatinine and cystatin C as predictors of liver damage, muscle strength and sarcopenia in liver disease.
    Ichikawa T; Miyaaki H; Miuma S; Motoyoshi Y; Yamashima M; Yamamichi S; Koike M; Takahashi Y; Honda T; Yajima H; Uehara R; Hino N; Hirata R; Taura N; Nakao K
    Biomed Rep; 2020 Mar; 12(3):89-98. PubMed ID: 32042417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of calculated body muscle mass and SARC-F as methods of screening for sarcopenia in patients with chronic liver disease.
    Ichikawa T; Miyaaki H; Miuma S; Motoyoshi Y; Yamashima M; Yamamichi S; Koike M; Nakano Y; Honda T; Yajima H; Uehara R; Miyazaki O; Kuribayashi Y; Kira K; Taura N; Nakao K
    Biomed Rep; 2021 Apr; 14(4):34. PubMed ID: 33732453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new index based on serum creatinine and cystatin C is useful for assessing sarcopenia in patients with advanced cancer.
    Fu X; Tian Z; Wen S; Sun H; Thapa S; Xiong H; Liu H; Li L; Yu S
    Nutrition; 2021 Feb; 82():111032. PubMed ID: 33172686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Creatinine/(cystatin C × body weight) ratio is associated with skeletal muscle mass index.
    Nishida K; Hashimoto Y; Kaji A; Okamura T; Sakai R; Kitagawa N; Osaka T; Hamaguchi M; Fukui M
    Endocr J; 2020 Jul; 67(7):733-740. PubMed ID: 32213726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Model to Identify Sarcopenia in Patients With Cirrhosis.
    Tandon P; Low G; Mourtzakis M; Zenith L; Myers RP; Abraldes JG; Shaheen AA; Qamar H; Mansoor N; Carbonneau M; Ismond K; Mann S; Alaboudy A; Ma M
    Clin Gastroenterol Hepatol; 2016 Oct; 14(10):1473-1480.e3. PubMed ID: 27189915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased the creatinine to cystatin C ratio is a surrogate marker of sarcopenia in patients with type 2 diabetes.
    Osaka T; Hamaguchi M; Hashimoto Y; Ushigome E; Tanaka M; Yamazaki M; Fukui M
    Diabetes Res Clin Pract; 2018 May; 139():52-58. PubMed ID: 29496508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calf circumference as a surrogate marker of muscle mass for diagnosing sarcopenia in Japanese men and women.
    Kawakami R; Murakami H; Sanada K; Tanaka N; Sawada SS; Tabata I; Higuchi M; Miyachi M
    Geriatr Gerontol Int; 2015 Aug; 15(8):969-76. PubMed ID: 25243821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new diagnostic index for sarcopenia and its association with short-term postoperative complications in patients undergoing surgery for colorectal cancer.
    Yang J; Zhang T; Feng D; Dai X; Lv T; Wang X; Gong J; Zhu W; Li J
    Colorectal Dis; 2019 May; 21(5):538-547. PubMed ID: 30648340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of serum creatinine-to-cystatin C ratio with skeletal muscle mass and strength in nonalcoholic fatty liver disease in the Iwaki Health Promotion Project.
    Mikami K; Endo T; Sawada N; Igarashi G; Kimura M; Hasegawa T; Iino C; Sawada K; Ando M; Sugimura Y; Mikami T; Nakaji S; Matsuzaka M; Sakuraba H; Fukuda S
    J Clin Biochem Nutr; 2022 May; 70(3):273-282. PubMed ID: 35692671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined grip strength and calf circumference as a useful prognostic system in patients with liver diseases: a large cohort study.
    Nishikawa H; Yoh K; Enomoto H; Nishimura T; Nishiguchi S; Iijima H
    Ann Transl Med; 2021 Apr; 9(8):624. PubMed ID: 33987322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship of creatinine cystatin C ratio with muscle mass and grip strength in memory clinic outpatients.
    Yamada Y; Umegaki H; Sugimoto T; Nagae M; Komiya H; Watanabe K; Sakurai T
    Exp Gerontol; 2022 Oct; 168():111935. PubMed ID: 36038035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum creatinine to cystatin C ratio reflects preoperative and early postoperative walking ability in older patients with hip fracture.
    Okubo N; Yoshida T; Tanaka K; Okada N; Hosoi K; Ohara M; Takahashi K
    J Cachexia Sarcopenia Muscle; 2022 Apr; 13(2):945-954. PubMed ID: 35170256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The sarcopenia index: A novel measure of muscle mass in lung transplant candidates.
    Kashani K; Sarvottam K; Pereira NL; Barreto EF; Kennedy CC
    Clin Transplant; 2018 Mar; 32(3):e13182. PubMed ID: 29274246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defining sarcopenia in terms of skeletal health.
    Kim JH; Hong AR; Choi HJ; Ku EJ; Lee JH; Cho NH; Shin CS
    Arch Osteoporos; 2018 Sep; 13(1):100. PubMed ID: 30238222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced leg muscle mass and lower grip strength in women are associated with osteoporotic vertebral compression fractures.
    Eguchi Y; Toyoguchi T; Orita S; Shimazu K; Inage K; Fujimoto K; Suzuki M; Norimoto M; Umimura T; Shiga Y; Inoue M; Koda M; Furuya T; Maki S; Hirosawa N; Aoki Y; Nakamura J; Hagiwara S; Akazawa T; Takahashi H; Takahashi K; Shiko Y; Kawasaki Y; Ohtori S
    Arch Osteoporos; 2019 Nov; 14(1):112. PubMed ID: 31760559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Creatinine index as a predictive marker of sarcopenia in patients under hemodialysis.
    Plytzanopoulou P; Politis P; Papachrysanthou T; Andriopoulos C; Drakou A; Papachristou E; Papastamatiou M; Papasotiriou M
    Int Urol Nephrol; 2022 Jul; 54(7):1565-1573. PubMed ID: 34674147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of the sarcopenia index to assess muscle mass in the critically ill: A novel application of kidney function markers.
    Barreto EF; Poyant JO; Coville HH; Dierkhising RA; Kennedy CC; Gajic O; Nystrom EM; Takahashi N; Moynagh MR; Kashani KB
    Clin Nutr; 2019 Jun; 38(3):1362-1367. PubMed ID: 29921462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cut-off points for weight and body mass index adjusted bioimpedance analysis measurements of muscle mass.
    Bahat G; Tufan A; Kilic C; Öztürk S; Akpinar TS; Kose M; Erten N; Karan MA; Cruz-Jentoft AJ
    Aging Clin Exp Res; 2019 Jul; 31(7):935-942. PubMed ID: 30267332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cut-off points to identify sarcopenia according to European Working Group on Sarcopenia in Older People (EWGSOP) definition.
    Bahat G; Tufan A; Tufan F; Kilic C; Akpinar TS; Kose M; Erten N; Karan MA; Cruz-Jentoft AJ
    Clin Nutr; 2016 Dec; 35(6):1557-1563. PubMed ID: 26922142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.